Susanne Bergh

AstraZeneca (United Kingdom)

Papers

1

Total Citations

16

H-Index

1

About

Susanne Bergh is a pioneering researcher in bioanalytical chemistry, with a primary focus on advancing high-throughput sample preparation techniques for pharmaceutical analysis. Her most cited work, a 2003 study on factorial design for automated solid-phase extraction in the 96-well format, revolutionized the determination of tesaglitazar in plasma using liquid chromatography–mass spectrometry. This contribution demonstrated her expertise in optimizing method development through systematic experimental design, significantly improving efficiency and reproducibility in drug quantification. With 16 citations, this paper remains a foundational reference for researchers seeking to streamline bioanalytical workflows. Bergh’s work bridges the gap between analytical chemistry and pharmacology, enabling faster, more reliable pharmacokinetic studies. Her achievements underscore a commitment to methodological innovation, making her a key figure in the evolution of automated sample preparation. For students and researchers, her research offers a model of how rigorous factorial design can transform complex analytical challenges into robust, scalable solutions.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Factorial design for the development of automated solid-phase extraction in the 96-well format for determination of tesaglitazar, in plasma, by liquid chromatography–mass spectrometry
16 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: AstraZeneca (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago